2nd Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$5,580,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

H.R. 1256 - Family Smoking and Prevention and Tobacco Control Act VA Drug Coverage Smoking Cessation Coverage

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
DOLLY JUDGE —
LOUIS A LAMARCA —

Contacted: Veterans Affairs, Dept of (VA); State, Dept of (DOS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Treasury, Dept of; Commerce, Dept of (DOC)

Bills named: H.R. 1256 (111th)

Agriculture AGR

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
ANTHONY PRINCIPI —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Treasury, Dept of; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2400 (111th), H.R. 1549 (111th)

Trade (domestic/foreign) TRD

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
STEPHANIE HENNING —
ANTHONY PRINCIPI —

Contacted: SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of; Patent & Trademark Office (PTO); Veterans Affairs, Dept of (VA)

Copyright/Patent/Trademark CPT

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOSEPH DAMOND —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: SENATE; Defense, Dept of (DOD); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA)

Bills named: H.R. 1260 (111th), S. 299 (111th), H.R. 1548 (111th), S. 610 (111th), S. 515 (111th), H.R. 1706 (111th), S. 369 (111th)

Medicare/Medicaid MMM

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
DOLLY JUDGE —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Defense, Dept of (DOD); Patent & Trademark Office (PTO)

Bills named: S. 75 (111th), H.R. 574 (111th), H.R. 684 (111th)

Budget/Appropriations BUD

H.R. 1 - The American Recovery and Reinvestment Act 2009 S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOSEPH DAMOND —
DOLLY JUDGE —
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Commerce, Dept of (DOC); SENATE; Executive Office of the President (EOP); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA)

Bills named: H.R. 1 (111th), H.Con.Res. 85 (111th), S.Con.Res. 13 (111th)

Consumer Issues/Safety/Products CSP

S.80 - Pharmaceutic Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO); Treasury, Dept of; Food & Drug Administration (FDA); Executive Office of the President (EOP)

Bills named: H.R. 1256 (111th), H.R. 163 (111th), S. 767 (111th), S. 882 (111th), H.R. 1548 (111th), H.R. 573 (111th), H.R. 91 (111th), H.R. 1427 (111th), S. 501 (111th), H.R. 759 (111th), S. 80 (111th)

Labor Issues/Antitrust/Workplace LBR

Wyeth Acquisition

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: Defense, Dept of (DOD); Executive Office of the President (EOP); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Treasury, Dept of; Food & Drug Administration (FDA); SENATE

Taxation/Internal Revenue Code TAX

H.R. 1 - American Recovery and Reinvestment Act of 2009 H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Repatriation

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: Food & Drug Administration (FDA); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Veterans Affairs, Dept of (VA)

Bills named: H.R. 2098 (111th), H.R. 422 (111th), H.R. 1 (111th), S. 1203 (111th), H.R. 198 (111th)

Health Issues HCR

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics

LobbyistCovered position, as disclosed
MELISSA BISHOP-MURPHY —
CHRISTOPHER CAREY —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Treasury, Dept of; State, Dept of (DOS); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS)

Bills named: S.Con.Res. 13 (111th), S. 4 (111th), S. 501 (111th), H.R. 1 (111th), H.R. 1548 (111th), H.R. 15 (111th), H.R. 2400 (111th), S. 726 (111th), S. 301 (111th), S. 717 (111th), S. 45 (111th), H.R. 2 (111th), H.Con.Res. 85 (111th), H.R. 1427 (111th), H.R. 1549 (111th), H.R. 2366 (111th), H.R. 193 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.